BIO-RAD LABORATORIES, INC. — Director's Dealing 2015

Aug 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-08-13

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Bio-Rad A Common Stock	M	7000	$62.47	Acquired	57965.5476	Direct
2015-08-13	Bio-Rad A Common Stock	S	1999	$146.75	Disposed	55966.5476	Direct
2015-08-13	Bio-Rad A Common Stock	S	2559	$147.57	Disposed	53407.5476	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-13	Non-Qualified Stock Option (right to buy)	$62.47	M	7000	Disposed	2016-04-03	Bio-Rad A Common Stock (7000)	Direct

Footnotes

F1: Includes 31.2067, 58.6524 and 60.3804 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/14, 3/31/15 and 6/30/15, respectively.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.21 to $147.19 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.35 to $147.75 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The option vested in five equal annual installments beginning on April 3, 2007.